160 related articles for article (PubMed ID: 8625545)
1. Clinical benefits and immunopathological correlates of intravenous immune globulin in the treatment of inflammatory myopathies.
Dalakas MC
Clin Exp Immunol; 1996 May; 104 Suppl 1():55-60. PubMed ID: 8625545
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials.
Dalakas MC
Neurol Sci; 2003 Oct; 24 Suppl 4():S256-9. PubMed ID: 14598055
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
Basta M; Dalakas MC
J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
[TBL] [Abstract][Full Text] [Related]
4. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches in patients with inflammatory myopathies.
Dalakas MC
Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
[TBL] [Abstract][Full Text] [Related]
6. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis.
Dalakas MC
Int Immunopharmacol; 2006 Apr; 6(4):550-6. PubMed ID: 16504918
[TBL] [Abstract][Full Text] [Related]
7. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
Raju R; Dalakas MC
Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
[TBL] [Abstract][Full Text] [Related]
9. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
Illa I
J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
Dalakas MC; Illa I; Dambrosia JM; Soueidan SA; Stein DP; Otero C; Dinsmore ST; McCrosky S
N Engl J Med; 1993 Dec; 329(27):1993-2000. PubMed ID: 8247075
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of inflammatory myopathies.
Dalakas MC
Ann Neurol; 1995 May; 37 Suppl 1():S74-86. PubMed ID: 8968219
[TBL] [Abstract][Full Text] [Related]
13. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
Soueidan SA; Dalakas MC
Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
[TBL] [Abstract][Full Text] [Related]
14. [Dysimmune and inflammatory myopathies].
Authier FJ
Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
[TBL] [Abstract][Full Text] [Related]
15. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
De Paepe B; Creus KK; De Bleecker JL
Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
[TBL] [Abstract][Full Text] [Related]
16. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
Chérin P; Herson S
Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
Quick A; Tandan R
Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
[TBL] [Abstract][Full Text] [Related]
18. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
Dalakas MC
J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
[TBL] [Abstract][Full Text] [Related]
19. Treatment of inflammatory myopathy with intravenous gamma globulin.
Sussman GL; Pruzanski W
Curr Opin Rheumatol; 1995 Nov; 7(6):510-5. PubMed ID: 8579971
[TBL] [Abstract][Full Text] [Related]
20. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins.
Tournadre A; Porcherot M; Chérin P; Marie I; Hachulla E; Miossec P
Cytokine; 2009 Jun; 46(3):297-301. PubMed ID: 19303320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
